Ionis Pharmaceuticals Inc 2023 SR

The report highlights Ionis Pharmaceuticals' progress in 2023, focusing on its three corporate responsibility pillars: innovating for serious diseases, empowering people and communities, and operating sustainably. Key achievements include the FDA approval of WAINUA and QALSODY, and positive Phase 3 results for three late-stage medicines. The company conducted its first CR materiality assessment and established new strategic goals. Environmentally, Ionis achieved 51% renewable energy use and reduced water consumption by 24% since 2021. Socially, it expanded its employee resource groups to nine and achieved a 73% employee engagement rate.

Company: Ionis Pharmaceuticals Inc

Sector: Health Care

Country: United States

Year: 2023

Type: SR

Pages: 42

Back to company

Ionis Pharmaceuticals Inc

Ionis Pharmaceuticals Inc 2023 Corporate Responsibility Report

Corporate Responsibility Report

The report highlights Ionis Pharmaceuticals' progress in 2023, focusing on its three corporate responsibility pillars: innovating for serious diseases, empowering people and communities, and operating sustainably. Key achievements include the FDA approval of WAINUA and QALSODY, and positive Phase 3 results for three late-stage medicines. The company conducted its first CR materiality assessment and established new strategic goals. Environmentally, Ionis achieved 51% renewable energy use and reduced water consumption by 24% since 2021. Socially, it expanded its employee resource groups to nine and achieved a 73% employee engagement rate.

Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.

Document Details

Report Year

2023

Reporting Period

Jan 1, 2023 - Dec 31, 2023

Fiscal Year

2023

Type

Sustainability Report

Language

English

Pages

 

File Size

 

Standards & Assurance

Reporting Standards

Materiality Assessment

Sustainable Development Goals

Other Standards

ESG Data?Experimental — AI-extracted data, may contain inaccuracies

Emissions

Scope 1:

Scope 2:

Energy Consumption

Renewable Energy

Water Consumption

Total Waste

Women on Board

Women in Management

Workplace Fatalities

Employees